Yingtai Medical to acquire at least 51% of Hangzhou Weiqiang Medical Technology

Yingtai Medical (01501) announced on December 18, 2024, that it has signed an acquisition意向协议 to acquire at least a 51% controlling stake in Hangzhou Weiqiang Medical Technology through capital increase and share acquisition, with a planned capital increase of no less than RMB 200 million.

“公司建议收购目标公司可进一步完善公司在主动脉及外周血管介入及植入领域的产品布局。”beta.zhitongcaijing.com

• 1 source
• beta.zhitongcaijing.com瑛泰医疗(01501)拟收购杭州唯强医疗科技至少51%股权的控股权益Dec 18, 2024

Summarized from public sources; check the original articles before acting on it.